Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation the Safety and Efficacy of the Treatment of Scars and Cutis Laxa Syndrome With the Use of Autologous (Fresh and Stored) Stem Cells Isolated From Adipose Tissue.

NCT03887208 is registered in ClinicalTrials.gov with Medical University of Warsaw as lead sponsor.

NCT NCT03887208
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03887208 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation the Safety and Efficacy of the Treatment of Scars and Cutis Laxa Syndrome With the Use of Autologous (Fresh and Stored) Stem Cells Isolated From Adipose Tissue.
Lead sponsor
Medical University of Warsaw
Phase
Phase 1/2
Overall status
Completed
Start date
January 31, 2018
Completion date
January 18, 2020
Enrollment
100 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

cicatrix, cutis laxa, keloid, scar, skin